Largest FDA-authorized Phase 2 cell therapy trial conducted in chronic lumbar disc diseaseThe study has enrolled a total of ...
Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...
A novel collaboration may establish a framework to help researchers overcome regulatory barriers they often face when ...
Leading vaccine researchers say that the proposed vaccine trials could lead to unreliable conclusions on already-approved ...
The benefits of exercise are limited, disappear if discontinued, and should be an adjunct to talk or drug therapy.
Revita-treated patients experienced sustained weight maintenance, improved cardiometabolic profile, and reduced food cravings ...
A large-scale study finds that most listed statin side effects are minimal, while the cardiovascular benefits dominate, prompting calls to revise labeling for clearer decision-making.
In combined analysis (n = 39), the average wound closure rate was 98%, and all 19 patients previously diagnosed for potential ...
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development ...
Solid Biosciences Inc. is a Strong Buy driven by positive FDA alignment on phase 3 IMPACT DUCHENNE trial for SGT-003. Read ...
Traditional stroke rehabilitation therapy focuses on restoring strength and movement to the more impaired side of the body, ...